跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLEXERIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FLEXERIL
Authorized
STANDARD
FLEXERIL
orimed pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0fec854ee4b4d575
Company
orimed pharma inc
Type
Standard
Approval Details
Approval Id
0fec854ee4b4d575
Drug Approval Canada Name
FLEXERIL
Product Name
FLEXERIL
Status
Dormant
Status Date
2023-07-05
Original Market Date
2020-03-20
Din
02495422
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:20.04
Atc Original
M03BX08 CYCLOBENZAPRINE
Atc Name
m 03 bx 08
Aig Number
0112363001
Company Name
orimed pharma inc
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0fec854ee4b4d575
Type
Standard
Back to Health Canada Approvals